Endoscopic Transmural Resection of a Neuroendocrine Tumor of the Appendix

摘要

A 51-year-old female patient with no relevant past medical history underwent colonoscopy for investigation of iron-deficiency anemia. Colonoscopy revealed a yellowish subepithelial lesion located in the appendix, 15 mm in size (Fig. ). Biopsies showed a well-differentiated neuroendocrine tumor (NET G1). Additionally, the patient underwent a thoracic-abdominal-pelvic computed tomography (CT) scan and Octreoscan®, showing no lymph node involvement or distant metastases. The patient was referred to our center for transmural endoscopic resection, using the full-thickness resection device (FTRD®; Ovesco Endoscopy AG). The FTRD is an over-the-scope system mounted on a standard colonoscope, composed of a plastic cap with a modified over-the-scope clip (OTSC®; Ovesco Endoscopy AG), a preloaded snare (13 mm) that runs along the outer surface of the colonoscope under a plastic sheath and a grasper, used in the working channel. The procedure was performed under anesthesiologist-administered propofol deep sedation, with periprocedural administration of intravenous cefazoline and metronidazole. After identification and marking of the margins of the lesion, the FTRD was mounted on the colonoscope (CF-H190 Evis Exera III Videocolonoscope®; Olympus Europe) (Fig. ). The lesion was then slowly pulled into the cap with the grasper, followed by OTSC deployment and excision of the pseudopolyp created by the OTSC with the preloaded snare (settings: Cut 1, Level 120, ESG-100, Olympus®). The specimen was recovered and sent pinned on styrofoam for histopathological analysis. The resection site was re-evaluated, showing no residual lesion (Fig. ). The patient was under prophylactic oral antibiotics for 7 days after the procedure. There were no early or delayed adverse events. The resection specimen consisted of a full-thickness wall colonic fragment measuring 28 × 18 mm, centered by a 13-mm yellow submucosal nodule. The histology showed a NET G1 (0 mitosis/10 high-power field, Ki67 1%) with infiltration of the subserosa (< 1 mm), no lymphovascular or perineural invasion, and negative lateral and deep margins (pT1b according to the UICC/AJCC classification and pT2 according to the ENETS guidelines) (Fig. ). After the procedure, the patient underwent a Ga-DOTA-NOC positron emission tomography/CT revealing no active disease. The case was discussed in the multidisciplinary board of neuroendocrine tumors, and surveillance with chromogranin A and an abdominal-pelvic CT scan was proposed. Currently, after 1 year of follow-up, there is no evidence of recurrence or distant metastases.